Large numbers of neurological cell models, covering various types of heterogeneous pathological mutations in NEU1 gene, are highly desirable to clearly define the neuropathological defects of sialidosis caused by NEU1 mutation and to develop novel therapeutic strategies. This evidence concerns the gene NEU1 and sialidosis.